The newly created Thumbay Research Institute for Precision Medicine will establish an interdisciplinary basic and translational cancer and diabetes research program to meet growing challenges facing UAE health care providers dealing with the increase in cancer burden and diabetes disease. It will focus its activities on comprehensive, translational research and personalised medicine, aims to become a centre of excellence and a leader in developing personalised medicine in the region. The centre will concentrate its activities on the development of state-of-the-art research technology platforms (liquid biopsy, NGS, functional genomics, imaging, gene editing) fundamental to position the centre in the international scene research field and as a regional leader in personalized cancer immunotherapy. Our ultimate goal is to position GMU among the leading research universities and a national model for medical education in the region by integrating innovation through research.
Thumbay Research Institute for Precision Medicine (TRIPM)
Leading the Innovation
Relevance of the Centre for the University and the Hospital
The TRIPM will serve as a bridge linking scientists, faculty members and clinicians who will work together in a synergistic manner in the frame of a well-focused program in order to reach scientific excellence in the research domain. We are building the most favorable environment for investigators and teams at the level of science, structure and equipment in order to make the TRIPM the most suitable environment for cancer research and diagnosis and a challenging initiative for seamless collaboration between research, education, healthcare and industry.